Cost-Effectiveness, Incompleteness, and Discrimination

被引:4
作者
Herlitz, Anders [1 ]
机构
[1] Inst Futures Studies, Box 591, S-10131 Stockholm, Sweden
基金
瑞典研究理事会;
关键词
QALY; discrimination; cost-effectiveness; healthcare rationing; HEALTH-CARE; INDETERMINACY; NONDETERMINACY;
D O I
10.1017/S0963180122000263
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
This paper argues that cost-effectiveness analysis in the healthcare sector introduces a discrimination risk that has thus far been underappreciated and outlines some approaches one can take toward this. It is argued that appropriate standards used in cost-effectiveness analysis in the healthcare sector fail to always fully determine an optimal option, which entails that cost-effectiveness analysis often leaves decision makers with large sets of permissible options. Larger sets of permissible options increase the role of decision makers' biases, whims, and prejudices, which means that the discrimination risk increases. Two ways of mitigating this are identified: tinkering with standards used in the cost-effectiveness analysis and outlining anti-discrimination guidelines for decision makers.
引用
收藏
页码:163 / 173
页数:11
相关论文
共 44 条
[1]  
Andersson H., 2022, Value incommensurability: Ethics, risk, and decisionmaking
[2]  
Andersson H, 2021, CLASSIFYING COMPARAB, P22
[3]  
Beckstead N, 2015, BIOETHICS ANTHOLOGY, P406
[4]   Equity weights in the allocation of health care: the rank-dependent QALY model [J].
Bleichrodt, H ;
Diecidue, E ;
Quiggin, J .
JOURNAL OF HEALTH ECONOMICS, 2004, 23 (01) :157-171
[5]  
BOGNAR G., 2014, ETHICS HLTH CARE RAT
[6]   AGE-WEIGHTING [J].
Bognar, Greg .
ECONOMICS AND PHILOSOPHY, 2008, 24 (02) :167-189
[7]  
Broome J., 2022, Value Incommensurability: Ethics, Risk, and Decision-Making
[8]  
Broome J, 2009, NOUS, P412
[9]  
Broome John., 1997, INCOMMENSURABILITY I
[10]   The possibility of parity [J].
Chang, R .
ETHICS, 2002, 112 (04) :659-688